ArticleJournal of clinical pharmacology2025

Pharmacokinetic and Exposure-Response Modeling Support Body Surface Area-Based Dosing of Farletuzumab Ecteribulin in Japanese Patients with Solid Tumors.

Seiichi Hayato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.